MiR-142-3p enhances chemosensitivity of breast cancer cells and inhibits autophagy by targeting HMGB1

• Główni autorzy: Lu Liang (Autor), Jijun Fu (Autor), Siran Wang (Autor), Huiyu Cen (Autor), Lingmin Zhang (Autor), Safur Rehman Mandukhail (Autor), Lingran Du (Autor), Qianni Wu (Autor), Peiquan Zhang (Autor), Xiyong Yu (Autor)
• Format: Książka
• Wydane: Elsevier, 2020-06-01T00:00:00Z.
• Hasła przedmiotowe: article
• Dostęp online: Connect to this object online.

MiR-142-3p has been reported to act as a tumor suppressor in breast cancer. However, the regulatory effect of miR-142-3p on drug resistance of breast cancer cells and its underlying mechanism remain unknown. Here, we found that miR-142-3p was significantly downregulated in the doxorubicin (DOX)-resi...